fluorodeoxyglucose f18 has been researched along with Cystadenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, A; Dong, H; Zuo, C | 1 |
| Okano, K; Oshima, M; Suzuki, Y; Yachida, S; Yamamoto, N | 1 |
| Agrawal, A; Gandhi, A; Patil, A; Purandare, NC; Puranik, AD; Rangarajan, V; Shah, S | 1 |
| Kaneta, T; Takahashi, S; Takanami, K; Yamada, S | 1 |
| Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N | 1 |
| Chierichetti, F; Decet, G; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Büll, U; Cremerius, U; Rath, W; Schröder, W; Wolters, S; Zimny, M | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Cystadenocarcinoma
| Article | Year |
|---|---|
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2010 |
6 other study(ies) available for fluorodeoxyglucose f18 and Cystadenocarcinoma
| Article | Year |
|---|---|
Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT.
Topics: Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Education and imaging. Hepatobiliary and pancreatic: intrahepatic biliary cystadenocarcinoma.
Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cystadenocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Use of FDG/PET CT to diagnose malignancy as the cause of mucocele of the appendix.
Topics: Appendix; Cecal Diseases; Cecal Neoplasms; Colectomy; Cystadenocarcinoma; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucocele; Perioperative Period; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
F-18 FDG PET/CT scan in biliary cystadenocarcinoma.
Topics: Aged; Biliary Tract Neoplasms; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed | 2005 |
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
Topics: Adult; Aged; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |